MiR-29c reduces the cisplatin resistance of non-small cell lung cancer cells by negatively regulating the PI3K/Akt pathway. [electronic resource]
Producer: 20191022Description: 8007 p. digitalISSN:- 2045-2322
- A549 Cells
- Adult
- Animals
- Carcinoma, Non-Small-Cell Lung -- drug therapy
- Case-Control Studies
- Cisplatin -- therapeutic use
- Down-Regulation -- genetics
- Drug Resistance, Neoplasm -- genetics
- Female
- Gene Expression Regulation, Neoplastic
- Genes, Tumor Suppressor -- physiology
- Humans
- Lung Neoplasms -- drug therapy
- Male
- Mice
- Mice, Nude
- MicroRNAs -- physiology
- Phosphatidylinositol 3-Kinases -- genetics
- Proto-Oncogene Proteins c-akt -- genetics
- Signal Transduction -- genetics
- Tumor Cells, Cultured
- Xenograft Model Antitumor Assays
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.